Immune checkpoint inhibitors: recent progress and potential biomarkers

Cancer growth and progression are associated with immune suppression. Cancer cells have the ability to activate different immune checkpoint pathways that harbor immunosuppressive functions. Monoclonal antibodies that target immune checkpoints provided an immense breakthrough in cancer therapeutics....

Descripción completa

Detalles Bibliográficos
Autores principales: Darvin, Pramod, Toor, Salman M., Sasidharan Nair, Varun, Elkord, Eyad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292890/
https://www.ncbi.nlm.nih.gov/pubmed/30546008
http://dx.doi.org/10.1038/s12276-018-0191-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292890/
https://www.ncbi.nlm.nih.gov/pubmed/30546008
http://dx.doi.org/10.1038/s12276-018-0191-1

Ejemplares similares